-
1
-
-
0034173535
-
Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: Basic aspects
-
Sarlis N.J. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer. basic aspects Reviews in Endocrine Metabolic Disorders. 1(3):2000;183-196.
-
(2000)
Reviews in Endocrine Metabolic Disorders
, vol.1
, Issue.3
, pp. 183-196
-
-
Sarlis, N.J.1
-
2
-
-
0002374069
-
Radiation and thyroid cancer
-
L. Wartofsky. Human Press: Totowa, NJ
-
Figge J.T., Jennings T., Gerasimov G. Radiation and thyroid cancer. Wartofsky L. Thyroid cancer. 2000;515 Totowa, NJ, Human Press.
-
(2000)
Thyroid cancer
, pp. 515
-
-
Figge, J.T.1
Jennings, T.2
Gerasimov, G.3
-
5
-
-
0142135720
-
Malignant disease of the thyroid and its relation to goiter in men and animals
-
Wegelin C. Malignant disease of the thyroid and its relation to goiter in men and animals. Cancer Reviews. 3:1929;297-301.
-
(1929)
Cancer Reviews
, vol.3
, pp. 297-301
-
-
Wegelin, C.1
-
7
-
-
1542354419
-
The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma
-
Bakiri F.et al. The relative roles of endemic goiter and socioeconomic development status in the prognosis of thyroid carcinoma. Cancer. 82:1998;1146-1152.
-
(1998)
Cancer
, vol.82
, pp. 1146-1152
-
-
Bakiri, F.1
-
8
-
-
0002521719
-
Molecular genetics of tumors of thyroid follicular cells
-
L.E. Braverman, & R.D. Utiger. Philadelphia, PA: Lippincott, Williams & Wilkins
-
Fagin J.A. Molecular genetics of tumors of thyroid follicular cells. Braverman L.E., Utiger R.D. Werner & Ingbar's the thyroid. 2000;886-898 Lippincott, Williams & Wilkins, Philadelphia, PA.
-
(2000)
Werner & Ingbar's the thyroid
, pp. 886-898
-
-
Fagin, J.A.1
-
10
-
-
0028339091
-
Molecular genetics of human thyroid neoplasms
-
Fagin J.A. Molecular genetics of human thyroid neoplasms. Annual Review of Medicine. 45(1):1994;45-52.
-
(1994)
Annual Review of Medicine
, vol.45
, Issue.1
, pp. 45-52
-
-
Fagin, J.A.1
-
11
-
-
0028316849
-
Molecular basis of thyroid cancer
-
Farid N.R., Shi Y., Zou M. Molecular basis of thyroid cancer. Endocrine Reviews. 15(2):1994;202-232.
-
(1994)
Endocrine Reviews
, vol.15
, Issue.2
, pp. 202-232
-
-
Farid, N.R.1
Shi, Y.2
Zou, M.3
-
14
-
-
0031746157
-
Genetic alterations in human epithelial thyroid tumours
-
Suárez H.G. Genetic alterations in human epithelial thyroid tumours. Clinical Endocrinology (Oxford). 48(5):1998;531-546.
-
(1998)
Clinical Endocrinology (Oxford)
, vol.48
, Issue.5
, pp. 531-546
-
-
Suárez, H.G.1
-
15
-
-
0025865948
-
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours
-
Wright P.A.et al. Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Oncogene. 6(9):1991;1693-1697.
-
(1991)
Oncogene
, vol.6
, Issue.9
, pp. 1693-1697
-
-
Wright, P.A.1
-
16
-
-
85025576916
-
Origin and progression of thyroid epithelial tumours: Cellular and molecular mechanisms
-
Wynford-Thomas D. Origin and progression of thyroid epithelial tumours. cellular and molecular mechanisms Hormone Research. 47(4-6):1997;145-157.
-
(1997)
Hormone Research
, vol.47
, Issue.4-6
, pp. 145-157
-
-
Wynford-Thomas, D.1
-
17
-
-
0034173353
-
Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma
-
Ringel M.D. Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma. Reviews of Endocrine Metabolic Disorders. 1(3):2000;173-181.
-
(2000)
Reviews of Endocrine Metabolic Disorders
, vol.1
, Issue.3
, pp. 173-181
-
-
Ringel, M.D.1
-
18
-
-
0033614998
-
Creation of human tumour cells with defined genetic elements
-
Hahn W.C.et al. Creation of human tumour cells with defined genetic elements. Nature. 400(6743):1999;464-468.
-
(1999)
Nature
, vol.400
, Issue.6743
, pp. 464-468
-
-
Hahn, W.C.1
-
19
-
-
0024399684
-
Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis
-
Weinberg R.A. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Research. 49:1989;3713-3721.
-
(1989)
Cancer Research
, vol.49
, pp. 3713-3721
-
-
Weinberg, R.A.1
-
20
-
-
0027455042
-
High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas
-
Fagin J.A.et al. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. Journal of Clinical Investigation. 91(1):1993;179-184.
-
(1993)
Journal of Clinical Investigation
, vol.91
, Issue.1
, pp. 179-184
-
-
Fagin, J.A.1
-
21
-
-
0031839748
-
Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas
-
Zou M.et al. Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas. Endocrine. 8(1):1998;61-64.
-
(1998)
Endocrine
, vol.8
, Issue.1
, pp. 61-64
-
-
Zou, M.1
-
22
-
-
0026763062
-
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype
-
Santoro M.et al. Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. Journal of Clinical Investigation. 89(5):1992;1517-1522.
-
(1992)
Journal of Clinical Investigation
, vol.89
, Issue.5
, pp. 1517-1522
-
-
Santoro, M.1
-
23
-
-
0034714190
-
PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma
-
Kroll T.G.et al. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma. Science. 289(5483):2000;1357-1360.
-
(2000)
Science
, vol.289
, Issue.5483
, pp. 1357-1360
-
-
Kroll, T.G.1
-
24
-
-
0035059613
-
Gene rearrangements in radiation-induced thyroid carcinogenesis
-
Rabes H.M. Gene rearrangements in radiation-induced thyroid carcinogenesis. Medical and Pediatric Oncology. 36(5):2001;574-582.
-
(2001)
Medical and Pediatric Oncology
, vol.36
, Issue.5
, pp. 574-582
-
-
Rabes, H.M.1
-
25
-
-
0033911338
-
Molecular genetics of thyroid tumors and surgical decision-making
-
Learoyd D.L.et al. Molecular genetics of thyroid tumors and surgical decision-making. World. 24(8):2000;923-933.
-
(2000)
World
, vol.24
, Issue.8
, pp. 923-933
-
-
Learoyd, D.L.1
-
26
-
-
0026316096
-
Growth factors and cancer
-
Aaronson S.A. Growth factors and cancer. Science. 254(5035):1991;1146- 1153.
-
(1991)
Science
, vol.254
, Issue.5035
, pp. 1146-1153
-
-
Aaronson, S.A.1
-
27
-
-
0021256332
-
Factors controlling proliferation and differentiation of canine thyroid cells cultured in reduced serum conditions: Effects of thyrotropin, cyclic amp and growth factors
-
Roger P.P., Dumont J.E. Factors controlling proliferation and differentiation of canine thyroid cells cultured in reduced serum conditions. effects of thyrotropin, cyclic amp and growth factors Molecular and Cellular Endocrinology. 36(1-2):1984;79-93.
-
(1984)
Molecular and Cellular Endocrinology
, vol.36
, Issue.1-2
, pp. 79-93
-
-
Roger, P.P.1
Dumont, J.E.2
-
28
-
-
0026743033
-
The thyrotropin receptor and the regulation of thyrocyte function and growth
-
Vassart G., Dumont J.E. The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrine Reviews. 13(3):1992;596-611.
-
(1992)
Endocrine Reviews
, vol.13
, Issue.3
, pp. 596-611
-
-
Vassart, G.1
Dumont, J.E.2
-
29
-
-
0027369421
-
Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas
-
Parma J.et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365(6447):1993;649-651.
-
(1993)
Nature
, vol.365
, Issue.6447
, pp. 649-651
-
-
Parma, J.1
-
31
-
-
7844239442
-
Iodide symporter gene expression in human thyroid tumors
-
Arturi F.et al. Iodide symporter gene expression in human thyroid tumors. Journal of Clinical Endocrinology and Metabolism. 83(7):1998;2493-2496.
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.7
, pp. 2493-2496
-
-
Arturi, F.1
-
32
-
-
0028588698
-
Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid
-
Paschke R.et al. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. Journal of Clinical Endocrinology and Metabolism. 79(6):1994;1785-1789.
-
(1994)
Journal of Clinical Endocrinology and Metabolism
, vol.79
, Issue.6
, pp. 1785-1789
-
-
Paschke, R.1
-
33
-
-
0028040908
-
Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy
-
Porcellini A.et al. Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. Journal of Clinical Endocrinology and Metabolism. 79(2):1994;657-661.
-
(1994)
Journal of Clinical Endocrinology and Metabolism
, vol.79
, Issue.2
, pp. 657-661
-
-
Porcellini, A.1
-
34
-
-
0028927822
-
Genetic alterations in thyroid hyperfunctioning adenomas
-
Russo D.et al. Genetic alterations in thyroid hyperfunctioning adenomas. Journal of Clinical Endocrinology and Metabolism. 80(4):1995;1347-1351.
-
(1995)
Journal of Clinical Endocrinology and Metabolism
, vol.80
, Issue.4
, pp. 1347-1351
-
-
Russo, D.1
-
35
-
-
0028808086
-
Activating mutations of the TSH receptor in differentiated thyroid carcinomas
-
Russo D.et al. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene. 11(9):1995;1907-1911.
-
(1995)
Oncogene
, vol.11
, Issue.9
, pp. 1907-1911
-
-
Russo, D.1
-
36
-
-
0029093051
-
Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan
-
Takeshita A.et al. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan. Journal of Clinical Endocrinology and Metabolism. 80(9):1995;2607-2611.
-
(1995)
Journal of Clinical Endocrinology and Metabolism
, vol.80
, Issue.9
, pp. 2607-2611
-
-
Takeshita, A.1
-
37
-
-
0029799977
-
Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: Low prevalence of mutations predicts infrequent involvement in malignant transformation
-
Spambalg D.et al. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers. low prevalence of mutations predicts infrequent involvement in malignant transformation Journal of Clinical Endocrinology and Metabolism. 81(11):1996;3898-3901.
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.11
, pp. 3898-3901
-
-
Spambalg, D.1
-
38
-
-
0026042003
-
Human thyrotropin receptor gene: Expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation
-
Brabant G.et al. Human thyrotropin receptor gene. expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation Molecular and Cellular Endocrinology. 82(1):1991;R7-R12.
-
(1991)
Molecular and Cellular Endocrinology
, vol.82
, Issue.1
-
-
Brabant, G.1
-
39
-
-
0027312835
-
Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis
-
Shi Y., Zou M., Farid N.R. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis. Clinical Endocrinology (Oxford). 39(3):1993;269-274.
-
(1993)
Clinical Endocrinology (Oxford)
, vol.39
, Issue.3
, pp. 269-274
-
-
Shi, Y.1
Zou, M.2
Farid, N.R.3
-
40
-
-
0027139794
-
Studies of the human TSH receptor gene in physiology and pathology
-
Shi Y.et al. Studies of the human TSH receptor gene in physiology and pathology. Hormone and Metabolic Research. 25(12):1993;632-636.
-
(1993)
Hormone and Metabolic Research
, vol.25
, Issue.12
, pp. 632-636
-
-
Shi, Y.1
-
41
-
-
84995819775
-
Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue
-
Bronnegard M.et al. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue. Journal of Clinical Endocrinology and Metabolism. 79(2):1994;384-389.
-
(1994)
Journal of Clinical Endocrinology and Metabolism
, vol.79
, Issue.2
, pp. 384-389
-
-
Bronnegard, M.1
-
42
-
-
0026730956
-
Analysis of human TSH receptor gene and RNA transcripts in patients with thyroid disorders
-
Cai W.Y.et al. Analysis of human TSH receptor gene and RNA transcripts in patients with thyroid disorders. Autoimmunity. 13(1):1992;43-50.
-
(1992)
Autoimmunity
, vol.13
, Issue.1
, pp. 43-50
-
-
Cai, W.Y.1
-
43
-
-
0026026818
-
The GTPase superfamily: Conserved structure and molecular mechanism
-
Bourne H.R., Sanders D.A., McCormick F. The GTPase superfamily. conserved structure and molecular mechanism Nature. 349(6305):1991;117-127.
-
(1991)
Nature
, vol.349
, Issue.6305
, pp. 117-127
-
-
Bourne, H.R.1
Sanders, D.A.2
McCormick, F.3
-
44
-
-
0025865247
-
Gsp mutations in human thyroid tumours
-
Suarez H.G.et al. Gsp mutations in human thyroid tumours. Oncogene. 6(4):1991;677-679.
-
(1991)
Oncogene
, vol.6
, Issue.4
, pp. 677-679
-
-
Suarez, H.G.1
-
45
-
-
0029053861
-
Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors
-
Hamacher C.et al. Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumors. Journal of Clinical Endocrinology and Metabolism. 80(5):1995;1724-1732.
-
(1995)
Journal of Clinical Endocrinology and Metabolism
, vol.80
, Issue.5
, pp. 1724-1732
-
-
Hamacher, C.1
-
46
-
-
0027325891
-
Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis
-
Yoshimoto K.et al. Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer- introduced restriction analysis. Cancer. 72(4):1993;1386-1393.
-
(1993)
Cancer
, vol.72
, Issue.4
, pp. 1386-1393
-
-
Yoshimoto, K.1
-
47
-
-
0026009016
-
Activating point mutations of the gsp oncogene in human thyroid adenomas
-
O'Sullivan C.et al. Activating point mutations of the gsp oncogene in human thyroid adenomas. Molecular Carcinogenesis. 4(5):1991;345-349.
-
(1991)
Molecular Carcinogenesis
, vol.4
, Issue.5
, pp. 345-349
-
-
O'Sullivan, C.1
-
48
-
-
0025127424
-
Two G protein oncogenes in human endocrine tumors
-
Lyons J.et al. Two G protein oncogenes in human endocrine tumors. Science. 249(4969):1990;655-659.
-
(1990)
Science
, vol.249
, Issue.4969
, pp. 655-659
-
-
Lyons, J.1
-
49
-
-
0030741024
-
Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice
-
Zeiger M.A.et al. Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. Endocrinology. 138(8):1997;3133-3140.
-
(1997)
Endocrinology
, vol.138
, Issue.8
, pp. 3133-3140
-
-
Zeiger, M.A.1
-
50
-
-
0027268702
-
Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N′-nitro-N- nitrosoguanidine (MNNG)
-
Michelin S.et al. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N′- nitro-N-nitrosoguanidine (MNNG). Oncogene. 8(7):1993;1983-1991.
-
(1993)
Oncogene
, vol.8
, Issue.7
, pp. 1983-1991
-
-
Michelin, S.1
-
51
-
-
0026664955
-
Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications
-
Goretzki P.E.et al. Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World Journal of Surgery. 16:1992;576-582.
-
(1992)
World Journal of Surgery
, vol.16
, pp. 576-582
-
-
Goretzki, P.E.1
-
52
-
-
0025285138
-
A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours
-
Clementi E.et al. A new constitutively activating mutation of the Gs protein alpha subunit-gsp oncogene is found in human pituitary tumours. Oncogene. 5(7):1990;1059-1061.
-
(1990)
Oncogene
, vol.5
, Issue.7
, pp. 1059-1061
-
-
Clementi, E.1
-
53
-
-
0030458390
-
Transformation of rat thyroid follicular cells stably transfected with cholera toxin A1 fragment
-
Zeiger M.A.et al. Transformation of rat thyroid follicular cells stably transfected with cholera toxin A1 fragment. Endocrinology. 137(12):1996;5392- 5399.
-
(1996)
Endocrinology
, vol.137
, Issue.12
, pp. 5392-5399
-
-
Zeiger, M.A.1
-
54
-
-
0025032745
-
Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues
-
(discussion 418)
-
Duh Q.Y.et al. Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues. World Journal of Surgery. 14(3):1990;410-417. (discussion 418).
-
(1990)
World Journal of Surgery
, vol.14
, Issue.3
, pp. 410-417
-
-
Duh, Q.Y.1
-
55
-
-
0024998117
-
Control of protein synthesis by thyrotropin and epidermal growth factor in human thyrocytes: Role of morphological changes
-
Lamy F.et al. Control of protein synthesis by thyrotropin and epidermal growth factor in human thyrocytes. role of morphological changes Molecular and Cellular Endocrinology. 73(2-3):1990;195-209.
-
(1990)
Molecular and Cellular Endocrinology
, vol.73
, Issue.2-3
, pp. 195-209
-
-
Lamy, F.1
-
56
-
-
0023944181
-
Differential protein phosphorylation in induction of thyroid cell proliferation by thyrotropin, epidermal growth factor, or phorbol ester
-
Contor L.et al. Differential protein phosphorylation in induction of thyroid cell proliferation by thyrotropin, epidermal growth factor, or phorbol ester. Molecular and Cellular Biology. 8(6):1988;2494-2503.
-
(1988)
Molecular and Cellular Biology
, vol.8
, Issue.6
, pp. 2494-2503
-
-
Contor, L.1
-
57
-
-
0026075028
-
Abnormalities of the EGF receptor system in human thyroid neoplasia
-
Lemoine N.R.et al. Abnormalities of the EGF receptor system in human thyroid neoplasia. International Journal of Cancer. 49(4):1991;558-561.
-
(1991)
International Journal of Cancer
, vol.49
, Issue.4
, pp. 558-561
-
-
Lemoine, N.R.1
-
58
-
-
0025964779
-
Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues
-
Mizukami Y.et al. Immunohistochemical demonstration of epidermal growth factor and c-myc oncogene product in normal, benign and malignant thyroid tissues. Histopathology. 18(1):1991;11-18.
-
(1991)
Histopathology
, vol.18
, Issue.1
, pp. 11-18
-
-
Mizukami, Y.1
-
59
-
-
0025296417
-
Epidermal growth factor receptor and thyrotropin response in human thyroid tissues
-
Di Carlo A.et al. Epidermal growth factor receptor and thyrotropin response in human thyroid tissues. Journal of Endocrinological Investigation. 13(4):1990;293-299.
-
(1990)
Journal of Endocrinological Investigation
, vol.13
, Issue.4
, pp. 293-299
-
-
Di Carlo, A.1
-
60
-
-
0023885771
-
Expression of oncogenes in thyroid tumours: Coexpression of c-erbB2/neu and c-erbB
-
Aasland R.et al. Expression of oncogenes in thyroid tumours. coexpression of c-erbB2/neu and c-erbB British Journal of Cancer. 57(4):1988;358-363.
-
(1988)
British Journal of Cancer
, vol.57
, Issue.4
, pp. 358-363
-
-
Aasland, R.1
-
61
-
-
0034714513
-
Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells
-
Bergstrom J.D., Westermark B., Heldin N.E. Epidermal growth factor receptor signaling activates met in human anaplastic thyroid carcinoma cells. Experimental Cell Research. 259(1):2000;293-299.
-
(2000)
Experimental Cell Research
, vol.259
, Issue.1
, pp. 293-299
-
-
Bergstrom, J.D.1
Westermark, B.2
Heldin, N.E.3
-
62
-
-
0032778530
-
Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features
-
Bunone G.et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. American Journal of the Pathology. 155(6):1999;1967-1976.
-
(1999)
American Journal of the Pathology
, vol.155
, Issue.6
, pp. 1967-1976
-
-
Bunone, G.1
-
63
-
-
0034116116
-
The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults
-
Fenton C.et al. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults. Thyroid. 10(4):2000;349-357.
-
(2000)
Thyroid
, vol.10
, Issue.4
, pp. 349-357
-
-
Fenton, C.1
-
64
-
-
0024516913
-
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue
-
Minuto F.et al. Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. Journal of Clinical Endocrinology and Metabolism. 68(3):1989;621-626.
-
(1989)
Journal of Clinical Endocrinology and Metabolism
, vol.68
, Issue.3
, pp. 621-626
-
-
Minuto, F.1
-
66
-
-
0029052357
-
Insulin-like growth factor binding protein production in human follicular thyroid carcinoma cells
-
Bachrach L.K.et al. Insulin-like growth factor binding protein production in human follicular thyroid carcinoma cells. Growth Regulation. 5(2):1995;109-118.
-
(1995)
Growth Regulation
, vol.5
, Issue.2
, pp. 109-118
-
-
Bachrach, L.K.1
-
67
-
-
0023891755
-
Loss of dependence on IGF-1 for proliferation of human thyroid adenoma cells
-
Williams D.W., Williams E.D., Wynford-Thomas D. Loss of dependence on IGF-1 for proliferation of human thyroid adenoma cells. British Journal of Cancer. 57(6):1988;535-539.
-
(1988)
British Journal of Cancer
, vol.57
, Issue.6
, pp. 535-539
-
-
Williams, D.W.1
Williams, E.D.2
Wynford-Thomas, D.3
-
68
-
-
0023572349
-
Thyroid angiogenesis: Endotheliotropic chemoattractant activity from rat thyroid cells in culture
-
Goodman A.L., Rone J.D. Thyroid angiogenesis. endotheliotropic chemoattractant activity from rat thyroid cells in culture Endocrinology. 121(6):1987;2131-2140.
-
(1987)
Endocrinology
, vol.121
, Issue.6
, pp. 2131-2140
-
-
Goodman, A.L.1
Rone, J.D.2
-
69
-
-
0025119463
-
Scatter factor: Molecular characteristics and effect on the invasiveness of epithelial cells
-
Weidner K.M.et al. Scatter factor. molecular characteristics and effect on the invasiveness of epithelial cells Journal of Cellular Biology. 111(5 Part 1):1990;2097-2108.
-
(1990)
Journal of Cellular Biology
, vol.111
, Issue.5 PART 1
, pp. 2097-2108
-
-
Weidner, K.M.1
-
70
-
-
0029924321
-
Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor
-
Eccles N., Ivan M., Wynford-Thomas D. Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor. Molecular and Cellular Endocrinology. 117(2):1996;247-251.
-
(1996)
Molecular and Cellular Endocrinology
, vol.117
, Issue.2
, pp. 247-251
-
-
Eccles, N.1
Ivan, M.2
Wynford-Thomas, D.3
-
71
-
-
0026441272
-
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas
-
Di Renzo M.F.et al. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene. 7(12):1992;2549-2553.
-
(1992)
Oncogene
, vol.7
, Issue.12
, pp. 2549-2553
-
-
Di Renzo, M.F.1
-
72
-
-
0027369598
-
Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase
-
Rodrigues G.A., Park M. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Molecular and Cellular Biology. 13(11):1993;6711-6722.
-
(1993)
Molecular and Cellular Biology
, vol.13
, Issue.11
, pp. 6711-6722
-
-
Rodrigues, G.A.1
Park, M.2
-
73
-
-
0022472582
-
Mechanism of met oncogene activation
-
Park M.et al. Mechanism of met oncogene activation. Cell. 45(6):1986;895-904.
-
(1986)
Cell
, vol.45
, Issue.6
, pp. 895-904
-
-
Park, M.1
-
74
-
-
0027348905
-
Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells
-
Comoglio P.M. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells. EXS. 65:1993;131-165.
-
(1993)
EXS
, vol.65
, pp. 131-165
-
-
Comoglio, P.M.1
-
75
-
-
0025999940
-
Expression of the Met/HGF receptor in normal and neoplastic human tissues
-
Di Renzo M.F.et al. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 6(11):1991;1997-2003.
-
(1991)
Oncogene
, vol.6
, Issue.11
, pp. 1997-2003
-
-
Di Renzo, M.F.1
-
76
-
-
0031006805
-
Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells
-
Ivan M.et al. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene. 14(20):1997;2417-2423.
-
(1997)
Oncogene
, vol.14
, Issue.20
, pp. 2417-2423
-
-
Ivan, M.1
-
77
-
-
0029844369
-
Expression of Met protein in thyroid tumours
-
Ruco L.P.et al. Expression of Met protein in thyroid tumours. Journal of Pathology. 180(3):1996;266-270.
-
(1996)
Journal of Pathology
, vol.180
, Issue.3
, pp. 266-270
-
-
Ruco, L.P.1
-
78
-
-
8544260294
-
Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases
-
Belfiore A.et al. Negative/low expression of the Met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. Journal of Clinical Endocrinology and Metabolism. 82(7):1997;2322-2328.
-
(1997)
Journal of Clinical Endocrinology and Metabolism
, vol.82
, Issue.7
, pp. 2322-2328
-
-
Belfiore, A.1
-
79
-
-
0026099022
-
The MYC protein activates transcription of the alpha-prothymosin gene
-
Eilers M., Schirm S., Bishop J.M. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO Journal. 10(1):1991;133-141.
-
(1991)
EMBO Journal
, vol.10
, Issue.1
, pp. 133-141
-
-
Eilers, M.1
Schirm, S.2
Bishop, J.M.3
-
80
-
-
0026665523
-
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
-
Amati B.et al. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature. 359(6394):1992;423-426.
-
(1992)
Nature
, vol.359
, Issue.6394
, pp. 423-426
-
-
Amati, B.1
-
81
-
-
0027533679
-
Oncogenic activity of the c-Myc protein requires dimerization with Max
-
Amati B.et al. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell. 72(2):1993;233-245.
-
(1993)
Cell
, vol.72
, Issue.2
, pp. 233-245
-
-
Amati, B.1
-
82
-
-
0025607921
-
New light on Myc and Myb. Part I. Myc
-
Luscher B., Eisenman R.N. New light on Myc and Myb. Part I. Myc. Genes and Development. 4(12A):1990;2025-2035.
-
(1990)
Genes and Development
, vol.4
, Issue.12 A
, pp. 2025-2035
-
-
Luscher, B.1
Eisenman, R.N.2
-
83
-
-
0022475016
-
Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture
-
Colletta G., Cirafici A.M., Vecchio G. Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture. Science. 233(4762):1986;458-460.
-
(1986)
Science
, vol.233
, Issue.4762
, pp. 458-460
-
-
Colletta, G.1
Cirafici, A.M.2
Vecchio, G.3
-
84
-
-
0023870902
-
Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas
-
Terrier P.et al. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. British Journal of Cancer. 57(1):1988;43-47.
-
(1988)
British Journal of Cancer
, vol.57
, Issue.1
, pp. 43-47
-
-
Terrier, P.1
-
85
-
-
0024460203
-
Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis
-
Wyllie F.S.et al. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis. British Journal of Cancer. 60(4):1989;561-565.
-
(1989)
British Journal of Cancer
, vol.60
, Issue.4
, pp. 561-565
-
-
Wyllie, F.S.1
-
86
-
-
0022972193
-
Expression of the myc cellular proto-oncogene in human thyroid tissue
-
Yamashita S.et al. Expression of the myc cellular proto-oncogene in human thyroid tissue. Journal of Clinical Endocrinology and Metabolism. 63(5):1986;1170-1173.
-
(1986)
Journal of Clinical Endocrinology and Metabolism
, vol.63
, Issue.5
, pp. 1170-1173
-
-
Yamashita, S.1
-
88
-
-
0027180099
-
Predisposition to neoplastic transformation caused by gene replacement of H-ras1
-
Finney R.E., Bishop J.M. Predisposition to neoplastic transformation caused by gene replacement of H-ras1. Science. 260(5113):1993;1524-1527.
-
(1993)
Science
, vol.260
, Issue.5113
, pp. 1524-1527
-
-
Finney, R.E.1
Bishop, J.M.2
-
89
-
-
0026781160
-
Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells
-
Studer H.et al. Histomorphological and immunohistochemical evidence that human nodular goiters grow by episodic replication of multiple clusters of thyroid follicular cells. Journal of Clinical Endocrinology and Metabolism. 75(4):1992;1151-1158.
-
(1992)
Journal of Clinical Endocrinology and Metabolism
, vol.75
, Issue.4
, pp. 1151-1158
-
-
Studer, H.1
-
90
-
-
0026446688
-
Multiple mechanisms of interference between transformation and differentiation in thyroid cells
-
Francis-Lang H.et al. Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Molecular and Cellular Biology. 12(12):1992;5793-5800.
-
(1992)
Molecular and Cellular Biology
, vol.12
, Issue.12
, pp. 5793-5800
-
-
Francis-Lang, H.1
-
91
-
-
0027498052
-
Molecular basis of epithelial tumorigenesis: The thyroid model
-
Wynford-Thomas D. Molecular basis of epithelial tumorigenesis. the thyroid model Critical Review of Oncogogenesis. 4:1993;1-23.
-
(1993)
Critical Review of Oncogogenesis
, vol.4
, pp. 1-23
-
-
Wynford-Thomas, D.1
-
92
-
-
0030061770
-
Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter
-
Rochefort P.et al. Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene. 12(1):1996;111-118.
-
(1996)
Oncogene
, vol.12
, Issue.1
, pp. 111-118
-
-
Rochefort, P.1
-
93
-
-
0027439205
-
Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter
-
Santelli G.et al. Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter. Cancer Research. 53(22):1993;5523-5527.
-
(1993)
Cancer Research
, vol.53
, Issue.22
, pp. 5523-5527
-
-
Santelli, G.1
-
94
-
-
0025859867
-
High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area
-
Shi Y.F.et al. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area. Cancer Research. 51(10):1991;2690-2693.
-
(1991)
Cancer Research
, vol.51
, Issue.10
, pp. 2690-2693
-
-
Shi, Y.F.1
-
95
-
-
0026026458
-
Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation
-
Wright P.A.et al. Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation. Oncogene. 6(3):1991;471-473.
-
(1991)
Oncogene
, vol.6
, Issue.3
, pp. 471-473
-
-
Wright, P.A.1
-
96
-
-
0024306507
-
High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma
-
Bongarzone I.et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene. 4(12):1989;1457-1462.
-
(1989)
Oncogene
, vol.4
, Issue.12
, pp. 1457-1462
-
-
Bongarzone, I.1
-
97
-
-
0023198108
-
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases
-
Fusco A.et al. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature. 328(6126):1987;170-172.
-
(1987)
Nature
, vol.328
, Issue.6126
, pp. 170-172
-
-
Fusco, A.1
-
98
-
-
0025282548
-
H-ras protooncogene mutations in human thyroid neoplasms
-
Namba H.et al. H-ras protooncogene mutations in human thyroid neoplasms. Journal of Clinical Endocrinology and Metabolism. 71(1):1990;223-229.
-
(1990)
Journal of Clinical Endocrinology and Metabolism
, vol.71
, Issue.1
, pp. 223-229
-
-
Namba, H.1
-
99
-
-
0026040262
-
Ras oncogene mutations in benign and malignant thyroid neoplasms
-
Karga H.et al. Ras oncogene mutations in benign and malignant thyroid neoplasms. Journal of Clinical Endocrinology and Metabolism. 73(4):1991;832-836.
-
(1991)
Journal of Clinical Endocrinology and Metabolism
, vol.73
, Issue.4
, pp. 832-836
-
-
Karga, H.1
-
100
-
-
0034828723
-
Ras mutations are rare in solitary cold and toxic thyroid nodules
-
Krohn K.et al. Ras mutations are rare in solitary cold and toxic thyroid nodules. Clinical Endocrinology (Oxford). 55(2):2001;241-248.
-
(2001)
Clinical Endocrinology (Oxford)
, vol.55
, Issue.2
, pp. 241-248
-
-
Krohn, K.1
-
101
-
-
0033951970
-
N-ras mutation in poorly differentiated thyroid carcinomas: Correlation with bone metastases and inverse correlation to thyroglobulin expression
-
Basolo F.et al. N-ras mutation in poorly differentiated thyroid carcinomas. correlation with bone metastases and inverse correlation to thyroglobulin expression Thyroid. 10(1):2000;19-23.
-
(2000)
Thyroid
, vol.10
, Issue.1
, pp. 19-23
-
-
Basolo, F.1
-
102
-
-
0008212049
-
Prevalence of Ras mutations in thyroid neoplasia
-
Esapa C.T.et al. Prevalence of Ras mutations in thyroid neoplasia. Clinical Endocrinology (Oxford). 50(4):1999;529-535.
-
(1999)
Clinical Endocrinology (Oxford)
, vol.50
, Issue.4
, pp. 529-535
-
-
Esapa, C.T.1
-
103
-
-
0024560104
-
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
-
Lemoine N.R.et al. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene. 4(2):1989;159-164.
-
(1989)
Oncogene
, vol.4
, Issue.2
, pp. 159-164
-
-
Lemoine, N.R.1
-
104
-
-
0025185363
-
Point mutations of ras oncogenes are an early event in thyroid tumorigenesis
-
Namba H., Rubin S.A., Fagin J.A. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Molecular Endocrinology. 4(10):1990;1474-1479.
-
(1990)
Molecular Endocrinology
, vol.4
, Issue.10
, pp. 1474-1479
-
-
Namba, H.1
Rubin, S.A.2
Fagin, J.A.3
-
105
-
-
18444374405
-
Mutations of the BRAF gene in human cancer
-
Davies H.et al. Mutations of the BRAF gene in human cancer. Nature. 417(6892):2002;949-954.
-
(2002)
Nature
, vol.417
, Issue.6892
, pp. 949-954
-
-
Davies, H.1
-
106
-
-
0037194728
-
Tumorigenesis: Raf/ras oncogenes and mismatch-repair status
-
Rajagopalan H.et al. Tumorigenesis. raf/ras oncogenes and mismatch-repair status Nature. 418(6901):2002;934.
-
(2002)
Nature
, vol.418
, Issue.6901
, pp. 934
-
-
Rajagopalan, H.1
-
107
-
-
0038664387
-
BRAF mutation in papillary thyroid carcinoma
-
Cohen Y.et al. BRAF mutation in papillary thyroid carcinoma. Journal of the National Cancer Institute. 95(8):2003;625-627.
-
(2003)
Journal of the National Cancer Institute
, vol.95
, Issue.8
, pp. 625-627
-
-
Cohen, Y.1
-
108
-
-
0037379904
-
High prevalence of BRAF mutations in thyroid cancer: Genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
-
Kimura E.T.et al. High prevalence of BRAF mutations in thyroid cancer. genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma Cancer Research. 63(7):2003;1454-1457.
-
(2003)
Cancer Research
, vol.63
, Issue.7
, pp. 1454-1457
-
-
Kimura, E.T.1
-
109
-
-
0031773504
-
RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
-
Learoyd D.L.et al. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism. 83(10):1998;3631-3635.
-
(1998)
Journal of Clinical Endocrinology and Metabolism
, vol.83
, Issue.10
, pp. 3631-3635
-
-
Learoyd, D.L.1
-
110
-
-
2642671982
-
Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors
-
De Vita G.et al. Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors. Cell Growth and Differentiation. 9(1):1998;97-103.
-
(1998)
Cell Growth and Differentiation
, vol.9
, Issue.1
, pp. 97-103
-
-
De Vita, G.1
-
111
-
-
0026565264
-
Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC
-
Pierotti M.A.et al. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proceedings of the National Academy Science of the USA. 89(5):1992;1616-1620.
-
(1992)
Proceedings of the National Academy Science of the USA
, vol.89
, Issue.5
, pp. 1616-1620
-
-
Pierotti, M.A.1
-
112
-
-
0027523909
-
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A
-
Bongarzone I.et al. Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Molecular and Cellular Biology. 13(1):1993;358-366.
-
(1993)
Molecular and Cellular Biology
, vol.13
, Issue.1
, pp. 358-366
-
-
Bongarzone, I.1
-
113
-
-
0027955122
-
Molecular characterization of RET/PTC3; A novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma
-
Santoro M.et al. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma. Oncogene. 9(2):1994;509-516.
-
(1994)
Oncogene
, vol.9
, Issue.2
, pp. 509-516
-
-
Santoro, M.1
-
114
-
-
0029781186
-
Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer
-
Fugazzola L.et al. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene. 13(5):1996;1093-1097.
-
(1996)
Oncogene
, vol.13
, Issue.5
, pp. 1093-1097
-
-
Fugazzola, L.1
-
115
-
-
0031964510
-
Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5
-
Klugbauer S.et al. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5. Cancer Research. 58(2):1998;198-203.
-
(1998)
Cancer Research
, vol.58
, Issue.2
, pp. 198-203
-
-
Klugbauer, S.1
-
116
-
-
0033615042
-
The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas
-
Klugbauer S., Rabes H.M. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene. 18(30):1999;4388-4393.
-
(1999)
Oncogene
, vol.18
, Issue.30
, pp. 4388-4393
-
-
Klugbauer, S.1
Rabes, H.M.2
-
117
-
-
0034213402
-
Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma
-
Salassidis K.et al. Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma. Cancer Research. 60(11):2000;2786-2789.
-
(2000)
Cancer Research
, vol.60
, Issue.11
, pp. 2786-2789
-
-
Salassidis, K.1
-
118
-
-
0025923247
-
Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method
-
Ishizaka Y.et al. Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene. 6(9):1991;1667-1672.
-
(1991)
Oncogene
, vol.6
, Issue.9
, pp. 1667-1672
-
-
Ishizaka, Y.1
-
119
-
-
0026612388
-
Detection of the PTC/retTPC oncogene in human thyroid cancers
-
Jhiang S.M.et al. Detection of the PTC/retTPC oncogene in human thyroid cancers. Oncogene. 7(7):1992;1331-1337.
-
(1992)
Oncogene
, vol.7
, Issue.7
, pp. 1331-1337
-
-
Jhiang, S.M.1
-
120
-
-
0029821103
-
Ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: Implications for metastatic potential?
-
Sugg S.L.et al. Ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas. implications for metastatic potential? Journal of Clinical Endocrinology and Metabolism. 81(9):1996;3360-3365.
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.9
, pp. 3360-3365
-
-
Sugg, S.L.1
-
121
-
-
0029879618
-
Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region
-
Delvincourt C.et al. Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region. Clinical Biochemistry. 29(3):1996;267-271.
-
(1996)
Clinical Biochemistry
, vol.29
, Issue.3
, pp. 267-271
-
-
Delvincourt, C.1
-
122
-
-
0030929178
-
High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
-
Bounacer A.et al. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation. Oncogene. 15(11):1997;1263-1273.
-
(1997)
Oncogene
, vol.15
, Issue.11
, pp. 1263-1273
-
-
Bounacer, A.1
-
123
-
-
0028233525
-
Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas
-
Bongarzone I.et al. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Research. 54(11):1994;2979-2985.
-
(1994)
Cancer Research
, vol.54
, Issue.11
, pp. 2979-2985
-
-
Bongarzone, I.1
-
124
-
-
0026686316
-
Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas
-
Wajjwalku W.et al. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas. Japanese Journal of Cancer Research. 83(7):1992;671-675.
-
(1992)
Japanese Journal of Cancer Research
, vol.83
, Issue.7
, pp. 671-675
-
-
Wajjwalku, W.1
-
125
-
-
0028011995
-
Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia
-
Zou M., Shi Y., Farid N.R. Low rate of ret proto-oncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer. 73(1):1994;176-180.
-
(1994)
Cancer
, vol.73
, Issue.1
, pp. 176-180
-
-
Zou, M.1
Shi, Y.2
Farid, N.R.3
-
126
-
-
9244255770
-
Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice
-
Santoro M.et al. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene. 12(8):1996;1821-1826.
-
(1996)
Oncogene
, vol.12
, Issue.8
, pp. 1821-1826
-
-
Santoro, M.1
-
127
-
-
0030941779
-
Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children
-
Nikiforov Y.E.et al. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Research. 57(9):1997;1690-1694.
-
(1997)
Cancer Research
, vol.57
, Issue.9
, pp. 1690-1694
-
-
Nikiforov, Y.E.1
-
128
-
-
0030881411
-
Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis
-
Mizuno T.et al. Continued expression of a tissue specific activated oncogene in the early steps of radiation-induced human thyroid carcinogenesis. Oncogene. 15(12):1997;1455-1460.
-
(1997)
Oncogene
, vol.15
, Issue.12
, pp. 1455-1460
-
-
Mizuno, T.1
-
129
-
-
0035021108
-
Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer
-
Cheung C.C.et al. Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer. Journal of Clinical Endocrinology and Metabolism. 86(5):2001;2187-2190.
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.5
, pp. 2187-2190
-
-
Cheung, C.C.1
-
130
-
-
0036118397
-
Hurthle cell tumors: Using molecular techniques to define a novel classification system
-
Belchetz G.et al. Hurthle cell tumors. using molecular techniques to define a novel classification system Archives of Otolaryngology - Head and Neck Surgery. 128(3):2002;237-240.
-
(2002)
Archives of Otolaryngology - Head and Neck Surgery
, vol.128
, Issue.3
, pp. 237-240
-
-
Belchetz, G.1
-
131
-
-
0034335425
-
Molecular basis off Hurthle cell papillary thyroid carcinoma
-
Cheung C.C.et al. Molecular basis off Hurthle cell papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 85(2):2000;878-882.
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.2
, pp. 878-882
-
-
Cheung, C.C.1
-
132
-
-
0025721936
-
The trk family of tyrosine protein kinase receptors
-
Barbacid M.et al. The trk family of tyrosine protein kinase receptors. Biochimica et Biophysica Acta. 1072(2-3):1991;115-127.
-
(1991)
Biochimica et Biophysica Acta
, vol.1072
, Issue.2-3
, pp. 115-127
-
-
Barbacid, M.1
-
133
-
-
0025323817
-
Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development
-
Martin-Zanca D., Barbacid M., Parada L.F. Expression of the trk proto-oncogene is restricted to the sensory cranial and spinal ganglia of neural crest origin in mouse development. Genes Development. 4(5):1990;683-694.
-
(1990)
Genes Development
, vol.4
, Issue.5
, pp. 683-694
-
-
Martin-Zanca, D.1
Barbacid, M.2
Parada, L.F.3
-
134
-
-
0026600358
-
TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas
-
Greco A.et al. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene. 7(2):1992;237-242.
-
(1992)
Oncogene
, vol.7
, Issue.2
, pp. 237-242
-
-
Greco, A.1
-
135
-
-
0025912929
-
Localization of the TRK proto-oncogene to human chromosome bands 1q23-1q24
-
Morris C.M.et al. Localization of the TRK proto-oncogene to human chromosome bands 1q23-1q24. Oncogene. 6(6):1991;1093-1095.
-
(1991)
Oncogene
, vol.6
, Issue.6
, pp. 1093-1095
-
-
Morris, C.M.1
-
136
-
-
0030612266
-
Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes
-
Greco A.et al. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes. Genes Chromosomes and Cancer. 19(2):1997;112-123.
-
(1997)
Genes Chromosomes and Cancer
, vol.19
, Issue.2
, pp. 112-123
-
-
Greco, A.1
-
137
-
-
0028805220
-
The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain
-
Greco A.et al. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain. Molecular and Cellular Biology. 15(11):1995;6118-6127.
-
(1995)
Molecular and Cellular Biology
, vol.15
, Issue.11
, pp. 6118-6127
-
-
Greco, A.1
-
138
-
-
0033290322
-
Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells
-
Portella G.et al. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells. Oncology Research. 11(9):1999;421-427.
-
(1999)
Oncology Research
, vol.11
, Issue.9
, pp. 421-427
-
-
Portella, G.1
-
139
-
-
9344257862
-
Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma
-
Bongarzone I.et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 81(5):1996;2006-2009.
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.5
, pp. 2006-2009
-
-
Bongarzone, I.1
-
140
-
-
0028148191
-
The cyclin-dependent protein kinases and the control of cell division
-
Doree M., Galas S. The cyclin-dependent protein kinases and the control of cell division. FASEB Journal. 8(14):1994;1114-1121.
-
(1994)
FASEB Journal
, vol.8
, Issue.14
, pp. 1114-1121
-
-
Doree, M.1
Galas, S.2
-
141
-
-
0033779267
-
Cyclin D1 overexpression in thyroid carcinomas: Relation with clinico- pathological parameters, retinoblastoma gene product, and Ki67 labeling index
-
Basolo F.et al. Cyclin D1 overexpression in thyroid carcinomas. relation with clinico- pathological parameters, retinoblastoma gene product, and Ki67 labeling index Thyroid. 10(9):2000;741-746.
-
(2000)
Thyroid
, vol.10
, Issue.9
, pp. 741-746
-
-
Basolo, F.1
-
142
-
-
0027429033
-
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer
-
Jiang W.et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proceedings of the National Academy Science of the USA. 90(19):1993;9026-9030.
-
(1993)
Proceedings of the National Academy Science of the USA
, vol.90
, Issue.19
, pp. 9026-9030
-
-
Jiang, W.1
-
143
-
-
0036277917
-
Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma
-
Khoo M.L.et al. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism. 87(4):2002;1814-1818.
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.4
, pp. 1814-1818
-
-
Khoo, M.L.1
-
144
-
-
0033889242
-
The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer
-
Wang S.et al. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Modern Pathology. 13(8):2000;882-887.
-
(2000)
Modern Pathology
, vol.13
, Issue.8
, pp. 882-887
-
-
Wang, S.1
-
145
-
-
0028261383
-
Cyclin D1 expression is regulated by the retinoblastoma protein
-
Muller H.et al. Cyclin D1 expression is regulated by the retinoblastoma protein. Proceedings of the National Academy Science of the USA. 91(8):1994;2945-2949.
-
(1994)
Proceedings of the National Academy Science of the USA
, vol.91
, Issue.8
, pp. 2945-2949
-
-
Muller, H.1
-
146
-
-
0033955743
-
Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid
-
Erickson L.A.et al. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid. Modern Pathology. 13(2):2000;186-192.
-
(2000)
Modern Pathology
, vol.13
, Issue.2
, pp. 186-192
-
-
Erickson, L.A.1
-
147
-
-
0034887230
-
Loss of heterozygocity at the thyroid peroxidase gene locus in solitary cold thyroid nodules
-
Krohn K., Paschke R. Loss of heterozygocity at the thyroid peroxidase gene locus in solitary cold thyroid nodules. Thyroid. 11(8):2001;741-747.
-
(2001)
Thyroid
, vol.11
, Issue.8
, pp. 741-747
-
-
Krohn, K.1
Paschke, R.2
-
148
-
-
0033871561
-
Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule
-
Christensen L.et al. Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule. Clinical Endocrinology (Oxford). 53(2):2000;161-169.
-
(2000)
Clinical Endocrinology (Oxford)
, vol.53
, Issue.2
, pp. 161-169
-
-
Christensen, L.1
-
149
-
-
0032739855
-
The value of thyroid peroxidase immunohistochemistry for preoperative fine-needle aspiration diagnosis of the follicular variant of papillary thyroid cancer
-
De Micco C., Vassko V., Henry J.F. The value of thyroid peroxidase immunohistochemistry for preoperative fine-needle aspiration diagnosis of the follicular variant of papillary thyroid cancer. Surgery. 126(6):1999;1200-1204.
-
(1999)
Surgery
, vol.126
, Issue.6
, pp. 1200-1204
-
-
De Micco, C.1
Vassko, V.2
Henry, J.F.3
-
150
-
-
0031422797
-
Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration
-
Faroux M.J.et al. Evaluation of the monoclonal antibody antithyroperoxidase MoAb47 in the diagnostic decision of cold thyroid nodules by fine-needle aspiration. Pathology Research and Practice. 193(10):1997;705- 712.
-
(1997)
Pathology Research and Practice
, vol.193
, Issue.10
, pp. 705-712
-
-
Faroux, M.J.1
-
151
-
-
0029779564
-
Quantitative cytology and thyroperoxidase immunochemistry: New tools in evaluating thyroid nodules by fine-needle aspiration
-
Pluot M.et al. Quantitative cytology and thyroperoxidase immunochemistry. new tools in evaluating thyroid nodules by fine-needle aspiration Cancer Detection and Prevention. 20(4):1996;285-293.
-
(1996)
Cancer Detection and Prevention
, vol.20
, Issue.4
, pp. 285-293
-
-
Pluot, M.1
-
152
-
-
0028088731
-
Fine-needle aspiration of thyroid follicular neoplasm: Diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47
-
De Micco C.et al. Fine-needle aspiration of thyroid follicular neoplasm. diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47 Surgery. 116(6):1994;1031-1035.
-
(1994)
Surgery
, vol.116
, Issue.6
, pp. 1031-1035
-
-
De Micco, C.1
-
153
-
-
0027988744
-
Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine-needle aspiration biopsy
-
De Micco C.et al. Thyroid peroxidase immunodetection as a tool to assist diagnosis of thyroid nodules on fine-needle aspiration biopsy. European Journal of Endocrinology. 131(5):1994;474-479.
-
(1994)
European Journal of Endocrinology
, vol.131
, Issue.5
, pp. 474-479
-
-
De Micco, C.1
-
154
-
-
0027990240
-
Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules
-
Henry J.F.et al. Thyroperoxidase immunodetection for the diagnosis of malignancy on fine-needle aspiration of thyroid nodules. World Journal of Surgery. 18(4):1994;529-534.
-
(1994)
World Journal of Surgery
, vol.18
, Issue.4
, pp. 529-534
-
-
Henry, J.F.1
-
155
-
-
0027332554
-
Immunohistological differentiation of benign thyroid follicular cell tumors from malignant ones: Usefulness of anti-peroxidase and JT-95 antibodies
-
Yamashita H.et al. Immunohistological differentiation of benign thyroid follicular cell tumors from malignant ones. usefulness of anti-peroxidase and JT-95 antibodies Acta Pathologica Japanica. 43(11):1993;670-673.
-
(1993)
Acta Pathologica Japanica
, vol.43
, Issue.11
, pp. 670-673
-
-
Yamashita, H.1
-
156
-
-
0025862391
-
Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases
-
Song B. Immunohistochemical demonstration of epidermal growth factor receptor and ceruloplasmin in thyroid diseases. Acta Pathologica Japanica. 41(5):1991;336-343.
-
(1991)
Acta Pathologica Japanica
, vol.41
, Issue.5
, pp. 336-343
-
-
Song, B.1
-
157
-
-
0033724819
-
Immunohistochemical study of ceruloplasmin, lactoferrin and secretory component expression in neoplastic and non-neoplastic thyroid gland diseases
-
Kondi-Pafiti A.et al. Immunohistochemical study of ceruloplasmin, lactoferrin and secretory component expression in neoplastic and non-neoplastic thyroid gland diseases. Acta Oncologica. 39(6):2000;753-756.
-
(2000)
Acta Oncologica
, vol.39
, Issue.6
, pp. 753-756
-
-
Kondi-Pafiti, A.1
-
158
-
-
0023191010
-
Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas
-
Tuccari G., Barresi G. Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas. Histopathology. 11(7):1987;723-731.
-
(1987)
Histopathology
, vol.11
, Issue.7
, pp. 723-731
-
-
Tuccari, G.1
Barresi, G.2
-
159
-
-
0028412869
-
Differentiation of follicular adenoma and carcinoma of thyroid by immunohistochemical demonstration of ceruloplasmin
-
Vaideeswar P.et al. Differentiation of follicular adenoma and carcinoma of thyroid by immunohistochemical demonstration of ceruloplasmin. Indian Journal of Pathology and Microbiology. 37(2):1994;165-169.
-
(1994)
Indian Journal of Pathology and Microbiology
, vol.37
, Issue.2
, pp. 165-169
-
-
Vaideeswar, P.1
-
160
-
-
0023216690
-
Iron-binding proteins in thyroid tumours. An immunocytochemical study
-
Barresi G., Tuccari G. Iron-binding proteins in thyroid tumours. An immunocytochemical study. Pathology Research and Practice. 182(3):1987;344-351.
-
(1987)
Pathology Research and Practice
, vol.182
, Issue.3
, pp. 344-351
-
-
Barresi, G.1
Tuccari, G.2
-
161
-
-
0031816685
-
Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma
-
Gonzalez-Campora R.et al. Dipeptidyl aminopeptidase IV in the cytologic diagnosis of thyroid carcinoma. Diagnostic Cytopathology. 19(1):1998;4-8.
-
(1998)
Diagnostic Cytopathology
, vol.19
, Issue.1
, pp. 4-8
-
-
Gonzalez-Campora, R.1
-
162
-
-
0029919111
-
Expression of dipeptidyl aminopeptidase IV activity in thyroid tumours: A possible marker of thyroid malignancy
-
Tang A.C.et al. Expression of dipeptidyl aminopeptidase IV activity in thyroid tumours. a possible marker of thyroid malignancy Journal of Otolaryngology. 25(1):1996;14-19.
-
(1996)
Journal of Otolaryngology
, vol.25
, Issue.1
, pp. 14-19
-
-
Tang, A.C.1
-
163
-
-
0029944588
-
Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid diseases
-
Iwabuchi H.et al. Staining for dipeptidyl aminopeptidase IV activity in nodular thyroid diseases. Acta Cytologica. 40(2):1996;158-163.
-
(1996)
Acta Cytologica
, vol.40
, Issue.2
, pp. 158-163
-
-
Iwabuchi, H.1
-
164
-
-
0029747134
-
Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity
-
Zoro P.et al. Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity. Annales de Pathologie. 16(4):1996;261-265.
-
(1996)
Annales de Pathologie
, vol.16
, Issue.4
, pp. 261-265
-
-
Zoro, P.1
-
165
-
-
0026054869
-
Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases
-
Aratake Y.et al. Dipeptidyl aminopeptidase IV staining of cytologic preparations to distinguish benign from malignant thyroid diseases. American Journal of Clinical Pathology. 96(3):1991;306-310.
-
(1991)
American Journal of Clinical Pathology
, vol.96
, Issue.3
, pp. 306-310
-
-
Aratake, Y.1
-
166
-
-
0026713174
-
Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours
-
Kotani T.et al. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours. Journal of Pathology. 168(1):1992;41-45.
-
(1992)
Journal of Pathology
, vol.168
, Issue.1
, pp. 41-45
-
-
Kotani, T.1
-
167
-
-
0032530892
-
Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma
-
Chiappetta G.et al. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors. HMGI(Y) expression represents a potential diagnostic indicator of carcinoma Cancer Research. 58(18):1998;4193-4198.
-
(1998)
Cancer Research
, vol.58
, Issue.18
, pp. 4193-4198
-
-
Chiappetta, G.1
-
168
-
-
0035863368
-
High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases
-
Chiappetta G.et al. High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases. International Journal of Cancer. 91(2):2001;147-151.
-
(2001)
International Journal of Cancer
, vol.91
, Issue.2
, pp. 147-151
-
-
Chiappetta, G.1
-
169
-
-
0035959740
-
High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth
-
Pierantoni G.M.et al. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene. 20(43):2001;6132-6141.
-
(2001)
Oncogene
, vol.20
, Issue.43
, pp. 6132-6141
-
-
Pierantoni, G.M.1
-
170
-
-
0032005220
-
Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix
-
Bandiera A.et al. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix. Cancer Research. 58(3):1998;426-431.
-
(1998)
Cancer Research
, vol.58
, Issue.3
, pp. 426-431
-
-
Bandiera, A.1
-
171
-
-
0028860339
-
Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells
-
Berlingieri M.T.et al. Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Molecular and Cellular Biology. 15(3):1995;1545-1553.
-
(1995)
Molecular and Cellular Biology
, vol.15
, Issue.3
, pp. 1545-1553
-
-
Berlingieri, M.T.1
-
172
-
-
0034636039
-
Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias
-
Scala S.et al. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias. Proceedings of the National Academy Science of the USA. 97(8):2000;4256-4261.
-
(2000)
Proceedings of the National Academy Science of the USA
, vol.97
, Issue.8
, pp. 4256-4261
-
-
Scala, S.1
-
173
-
-
0033629416
-
The expression of the high mobility group I(Y) mRNA in thyroid cancers: Useful tool of differential diagnosis of thyroid nodules
-
Kim S.J., Ryu J.W., Choi D.S. The expression of the high mobility group I(Y) mRNA in thyroid cancers. useful tool of differential diagnosis of thyroid nodules Korean Journal of Internal Medicine. 15(1):2000;71-75.
-
(2000)
Korean Journal of Internal Medicine
, vol.15
, Issue.1
, pp. 71-75
-
-
Kim, S.J.1
Ryu, J.W.2
Choi, D.S.3
-
174
-
-
0025773123
-
Cyclins and cancer
-
Hunter T., Pines J. Cyclins and cancer. Cell. 66(6):1991;1071-1074.
-
(1991)
Cell
, vol.66
, Issue.6
, pp. 1071-1074
-
-
Hunter, T.1
Pines, J.2
-
175
-
-
0034099227
-
Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1)
-
Depoortere F.et al. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Molecular and Biology of the Cell. 11(3):2000;1061-1076.
-
(2000)
Molecular and Biology of the Cell
, vol.11
, Issue.3
, pp. 1061-1076
-
-
Depoortere, F.1
-
176
-
-
0024544081
-
Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter
-
Grubeck-Loebenstein B.et al. Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter. Journal of Clinical Investigation. 83(3):1989;764-770.
-
(1989)
Journal of Clinical Investigation
, vol.83
, Issue.3
, pp. 764-770
-
-
Grubeck-Loebenstein, B.1
-
177
-
-
0029906574
-
Expression of cytokines in the thyroid: Thyrocytes as potential cytokine producers
-
Aust G., Scherbaum W.A. Expression of cytokines in the thyroid. thyrocytes as potential cytokine producers Experimental and Clinical Endocrinology and Diabetes. 104(Suppl. 4):1996;64-67.
-
(1996)
Experimental and Clinical Endocrinology and Diabetes
, vol.104
, Issue.SUPPL. 4
, pp. 64-67
-
-
Aust, G.1
Scherbaum, W.A.2
-
178
-
-
0026654124
-
Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells
-
Pang X.P., Park M., Hershman J.M. Transforming growth factor-beta blocks protein kinase-A-mediated iodide transport and protein kinase-C-mediated DNA synthesis in FRTL-5 rat thyroid cells. Endocrinology. 131(1):1992;45-50.
-
(1992)
Endocrinology
, vol.131
, Issue.1
, pp. 45-50
-
-
Pang, X.P.1
Park, M.2
Hershman, J.M.3
-
179
-
-
0025021064
-
Immunocytochemically detectable TGF-beta associated with malignancy in thyroid epithelial neoplasia
-
Jasani B.et al. Immunocytochemically detectable TGF-beta associated with malignancy in thyroid epithelial neoplasia. Growth Factors. 2(2-3):1990;149-155.
-
(1990)
Growth Factors
, vol.2
, Issue.2-3
, pp. 149-155
-
-
Jasani, B.1
-
180
-
-
0031724669
-
Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma
-
Matoba H.et al. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma. Hormone and Metabolic Research. 30(10):1998;624-628.
-
(1998)
Hormone and Metabolic Research
, vol.30
, Issue.10
, pp. 624-628
-
-
Matoba, H.1
-
181
-
-
0029867216
-
Alterations of p53 and expression of WAF1/p21 in human thyroid tumors
-
Zedenius J.et al. Alterations of p53 and expression of WAF1/p21 in human thyroid tumors. Thyroid. 6(1):1996;1-9.
-
(1996)
Thyroid
, vol.6
, Issue.1
, pp. 1-9
-
-
Zedenius, J.1
-
182
-
-
0029844146
-
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues
-
Ito Y.et al. Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues. British Journal of Cancer. 74(8):1996;1269-1274.
-
(1996)
British Journal of Cancer
, vol.74
, Issue.8
, pp. 1269-1274
-
-
Ito, Y.1
-
183
-
-
0031873396
-
Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma
-
Resnick M.B.et al. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Modern Pathology. 11(8):1998;735-739.
-
(1998)
Modern Pathology
, vol.11
, Issue.8
, pp. 735-739
-
-
Resnick, M.B.1
-
184
-
-
0032587780
-
Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories
-
Tallini G.et al. Downregulation of p27KIP1 and Ki67/Mib1 labeling index support the classification of thyroid carcinoma into prognostically relevant categories. American Journal of Surgical Pathology. 23(6):1999;678-685.
-
(1999)
American Journal of Surgical Pathology
, vol.23
, Issue.6
, pp. 678-685
-
-
Tallini, G.1
-
185
-
-
0031594658
-
Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors
-
Erickson L.A.et al. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Modern Pathology. 11(2):1998;169-174.
-
(1998)
Modern Pathology
, vol.11
, Issue.2
, pp. 169-174
-
-
Erickson, L.A.1
-
186
-
-
0031788262
-
The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis
-
Wang S.et al. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Human Pathology. 29(11):1998;1304-1309.
-
(1998)
Human Pathology
, vol.29
, Issue.11
, pp. 1304-1309
-
-
Wang, S.1
-
187
-
-
0036120668
-
Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease
-
Khoo M.L.et al. Underexpression of p27/Kip in thyroid papillary microcarcinomas with gross metastatic disease. Archives of Otolaryngology - Head and Neck Surgery. 128(3):2002;253-257.
-
(2002)
Archives of Otolaryngology - Head and Neck Surgery
, vol.128
, Issue.3
, pp. 253-257
-
-
Khoo, M.L.1
-
188
-
-
0033861626
-
Cyclin-dependent kinase inhibitor p27(Kip1) expression in thyroid cells obtained by fine-needle aspiration biopsy: A preliminary report
-
Troncone G.et al. Cyclin-dependent kinase inhibitor p27(Kip1) expression in thyroid cells obtained by fine-needle aspiration biopsy. a preliminary
-
(2000)
Diagnostic Cytopathology
, vol.23
, Issue.2
, pp. 77-81
-
-
Troncone, G.1
-
190
-
-
0023261635
-
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
-
Lee W.H.et al. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 329(6140):1987;642-645.
-
(1987)
Nature
, vol.329
, Issue.6140
, pp. 642-645
-
-
Lee, W.H.1
-
191
-
-
0026526437
-
E2F: A link between the Rb tumor suppressor protein and viral oncoproteins
-
Nevins J.R. E2F. a link between the Rb tumor suppressor protein and viral oncoproteins Science. 258(5081):1992;424-429.
-
(1992)
Science
, vol.258
, Issue.5081
, pp. 424-429
-
-
Nevins, J.R.1
-
192
-
-
0027229136
-
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
-
Ewen M.E.et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell. 73(3):1993;487-497.
-
(1993)
Cell
, vol.73
, Issue.3
, pp. 487-497
-
-
Ewen, M.E.1
-
193
-
-
0025905183
-
The E2F transcription factor is a cellular target for the RB protein
-
Chellappan S.P.et al. The E2F transcription factor is a cellular target for the RB protein. Cell. 65(6):1991;1053-1061.
-
(1991)
Cell
, vol.65
, Issue.6
, pp. 1053-1061
-
-
Chellappan, S.P.1
-
194
-
-
0023731010
-
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
-
DeCaprio J.A.et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell. 54(2):1988;275-283.
-
(1988)
Cell
, vol.54
, Issue.2
, pp. 275-283
-
-
DeCaprio, J.A.1
-
195
-
-
0023914010
-
Association between an oncogene and an anti-oncogene: The adenovirus e1a proteins bind to the retinoblastoma gene product
-
Whyte P.et al. Association between an oncogene and an anti-oncogene. the adenovirus e1a proteins bind to the retinoblastoma gene product Nature. 334(6178):1988;124-129.
-
(1988)
Nature
, vol.334
, Issue.6178
, pp. 124-129
-
-
Whyte, P.1
-
196
-
-
0024809865
-
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product
-
Munger K.et al. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO Journal. 8(13):1989;4099-4105.
-
(1989)
EMBO Journal
, vol.8
, Issue.13
, pp. 4099-4105
-
-
Munger, K.1
-
198
-
-
0024968153
-
SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family
-
Ludlow J.W.et al. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell. 56(1):1989;57-65.
-
(1989)
Cell
, vol.56
, Issue.1
, pp. 57-65
-
-
Ludlow, J.W.1
-
199
-
-
0024851254
-
Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
-
Mihara K.et al. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science. 246(4935):1989;1300-1303.
-
(1989)
Science
, vol.246
, Issue.4935
, pp. 1300-1303
-
-
Mihara, K.1
-
200
-
-
0026530730
-
The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner
-
Shirodkar S.et al. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell. 68(1):1992;157-166.
-
(1992)
Cell
, vol.68
, Issue.1
, pp. 157-166
-
-
Shirodkar, S.1
-
202
-
-
0025949966
-
Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice
-
Ledent C.et al. Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. Endocrinology. 129(3):1991;1391-1401.
-
(1991)
Endocrinology
, vol.129
, Issue.3
, pp. 1391-1401
-
-
Ledent, C.1
-
203
-
-
0029035272
-
Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene
-
Ledent C.et al. Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene. Oncogene. 10(9):1995;1789-1797.
-
(1995)
Oncogene
, vol.10
, Issue.9
, pp. 1789-1797
-
-
Ledent, C.1
-
204
-
-
0028222604
-
Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland
-
Holm R., Nesland J.M. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland. Journal of Pathology. 172(3):1994;267-272.
-
(1994)
Journal of Pathology
, vol.172
, Issue.3
, pp. 267-272
-
-
Holm, R.1
Nesland, J.M.2
-
205
-
-
0026496885
-
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
-
Kastan M.B.et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71(4):1992;587-597.
-
(1992)
Cell
, vol.71
, Issue.4
, pp. 587-597
-
-
Kastan, M.B.1
-
206
-
-
0021616838
-
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
-
Maltzman W., Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Molecular and Cellular Biology. 4(9):1984;1689-1694.
-
(1984)
Molecular and Cellular Biology
, vol.4
, Issue.9
, pp. 1689-1694
-
-
Maltzman, W.1
Czyzyk, L.2
-
207
-
-
0026669469
-
P53 function and dysfunction
-
Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell. 70(4):1992;523-526.
-
(1992)
Cell
, vol.70
, Issue.4
, pp. 523-526
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
209
-
-
0024382760
-
The p53 proto-oncogene can act as a suppressor of transformation
-
Finlay C.A., Hinds P.W., Levine A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell. 57(7):1989;1083-1093.
-
(1989)
Cell
, vol.57
, Issue.7
, pp. 1083-1093
-
-
Finlay, C.A.1
Hinds, P.W.2
Levine, A.J.3
-
210
-
-
0026452949
-
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
-
Hartwell L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell. 71(4):1992;543-546.
-
(1992)
Cell
, vol.71
, Issue.4
, pp. 543-546
-
-
Hartwell, L.1
-
211
-
-
0025894713
-
P53 mutations in human cancers
-
Hollstein M.et al. p53 mutations in human cancers. Science. 253(5015):1991;49-53.
-
(1991)
Science
, vol.253
, Issue.5015
, pp. 49-53
-
-
Hollstein, M.1
-
212
-
-
0025633582
-
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
-
Malkin D.et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 250(4985):1990;1233-1238.
-
(1990)
Science
, vol.250
, Issue.4985
, pp. 1233-1238
-
-
Malkin, D.1
-
213
-
-
0023715595
-
A cancer family syndrome in twenty-four kindreds
-
Li F.P.et al. A cancer family syndrome in twenty-four kindreds. Cancer Research. 48(18):1988;5358-5362.
-
(1988)
Cancer Research
, vol.48
, Issue.18
, pp. 5358-5362
-
-
Li, F.P.1
-
214
-
-
0025634118
-
P53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
-
Baker S.J.et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Research. 50(23):1990;7717-7722.
-
(1990)
Cancer Research
, vol.50
, Issue.23
, pp. 7717-7722
-
-
Baker, S.J.1
-
215
-
-
0031050368
-
P53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells
-
Moretti F.et al. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells. Oncogene. 14(6):1997;729-740.
-
(1997)
Oncogene
, vol.14
, Issue.6
, pp. 729-740
-
-
Moretti, F.1
-
216
-
-
0026660344
-
Expression of the normal p53 gene induces differentiation of K562 cells
-
Feinstein E.et al. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene. 7(9):1992;1853-1857.
-
(1992)
Oncogene
, vol.7
, Issue.9
, pp. 1853-1857
-
-
Feinstein, E.1
-
217
-
-
0026561121
-
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
-
Donehower L.A.et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356(6366):1992;215-221.
-
(1992)
Nature
, vol.356
, Issue.6366
, pp. 215-221
-
-
Donehower, L.A.1
-
218
-
-
0030047639
-
Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53
-
Fagin J.A.et al. Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53. Cancer Research. 56(4):1996;765-771.
-
(1996)
Cancer Research
, vol.56
, Issue.4
, pp. 765-771
-
-
Fagin, J.A.1
-
220
-
-
0031758342
-
Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines
-
Chun Y.S., Saji M., Zeiger M.A. Overexpression of TTF-1 and PAX-8 restores thyroglobulin gene promoter activity in ARO and WRO cell lines. Surgery. 124(6):1998;1100-1105.
-
(1998)
Surgery
, vol.124
, Issue.6
, pp. 1100-1105
-
-
Chun, Y.S.1
Saji, M.2
Zeiger, M.A.3
-
221
-
-
0034776299
-
Thyroid dysgenesis caused by PAX8 mutation: The hypermutability with CpG dinucleotides at codon 31
-
Komatsu M.et al. Thyroid dysgenesis caused by PAX8 mutation. the hypermutability with CpG dinucleotides at codon 31 Journal of Pediatrics. 139(4):2001;597-599.
-
(2001)
Journal of Pediatrics
, vol.139
, Issue.4
, pp. 597-599
-
-
Komatsu, M.1
-
223
-
-
0032055851
-
PAX 8 activates the enhancer of the human thyroperoxidase gene
-
Esposito C.et al. PAX 8 activates the enhancer of the human thyroperoxidase gene. Biochemical Journal. 331(Part 1):1998;37-40.
-
(1998)
Biochemical Journal
, vol.331
, Issue.1 PART
, pp. 37-40
-
-
Esposito, C.1
-
224
-
-
0034926511
-
Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells
-
Kogai T.et al. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells. Endocrinology. 142(8):2001;3369-3379.
-
(2001)
Endocrinology
, vol.142
, Issue.8
, pp. 3369-3379
-
-
Kogai, T.1
-
226
-
-
0034077288
-
Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases
-
Puglisi F.et al. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases. Anticancer Research. 20(1A):2000;311-316.
-
(2000)
Anticancer Research
, vol.20
, Issue.1 A
, pp. 311-316
-
-
Puglisi, F.1
-
227
-
-
17344374131
-
PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis
-
Macchia P.E.et al. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nature Genetics. 19(1):1998;83-86.
-
(1998)
Nature Genetics
, vol.19
, Issue.1
, pp. 83-86
-
-
Macchia, P.E.1
-
228
-
-
0031777309
-
Follicular cells of the thyroid gland require Pax8 gene function
-
Mansouri A., Chowdhury K., Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nature Genetics. 19(1):1998;87-90.
-
(1998)
Nature Genetics
, vol.19
, Issue.1
, pp. 87-90
-
-
Mansouri, A.1
Chowdhury, K.2
Gruss, P.3
-
229
-
-
0028123016
-
Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms
-
Fabbro D.et al. Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Research. 54(17):1994;4744-4749.
-
(1994)
Cancer Research
, vol.54
, Issue.17
, pp. 4744-4749
-
-
Fabbro, D.1
-
230
-
-
0032709533
-
Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis
-
Ros P.et al. Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie. 81(4):1999;389-396.
-
(1999)
Biochimie
, vol.81
, Issue.4
, pp. 389-396
-
-
Ros, P.1
-
231
-
-
0034968216
-
Cytoplasmic accumulation of alpha-catenin in thyroid neoplasms
-
Baloch Z.W., Pasha T., LiVolsi V.A. Cytoplasmic accumulation of alpha-catenin in thyroid neoplasms. Head and Neck. 23(7):2001;573-578.
-
(2001)
Head and Neck
, vol.23
, Issue.7
, pp. 573-578
-
-
Baloch, Z.W.1
Pasha, T.2
LiVolsi, V.A.3
-
232
-
-
0036225260
-
E-cadherin expression in follicular carcinoma of the thyroid
-
Kato N.et al. E-cadherin expression in follicular carcinoma of the thyroid. Pathology International. 52(1):2002;13-18.
-
(2002)
Pathology International
, vol.52
, Issue.1
, pp. 13-18
-
-
Kato, N.1
-
233
-
-
0035088194
-
Clinical significance of E-cadherin expression in thyroid neoplasms
-
Naito A.et al. Clinical significance of E-cadherin expression in thyroid neoplasms. Journal of Surgical Oncology. 76(3):2001;176-180.
-
(2001)
Journal of Surgical Oncology
, vol.76
, Issue.3
, pp. 176-180
-
-
Naito, A.1
-
234
-
-
0031994558
-
Prognostic value of e-cadherin in papillary thyroid carcinoma
-
Walgenbach S.et al. Prognostic value of e-cadherin in papillary thyroid carcinoma. Chirurg. 69(2):1998;186-190.
-
(1998)
Chirurg
, vol.69
, Issue.2
, pp. 186-190
-
-
Walgenbach, S.1
-
235
-
-
0030956853
-
Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome
-
von Wasielewski R.et al. Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. Cancer Research. 57(12):1997;2501-2507.
-
(1997)
Cancer Research
, vol.57
, Issue.12
, pp. 2501-2507
-
-
Von Wasielewski, R.1
-
236
-
-
0029060074
-
Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas
-
Scheumman G.F.et al. Clinical significance of E-cadherin as a prognostic marker in thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism. 80(7):1995;2168-2172.
-
(1995)
Journal of Clinical Endocrinology and Metabolism
, vol.80
, Issue.7
, pp. 2168-2172
-
-
Scheumman, G.F.1
-
237
-
-
0032748291
-
Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue
-
Huang S.H.et al. Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue. Thyroid. 9(11):1999;1095-1103.
-
(1999)
Thyroid
, vol.9
, Issue.11
, pp. 1095-1103
-
-
Huang, S.H.1
-
238
-
-
15144350589
-
Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma
-
Graff J.R.et al. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma. Cancer Research. 58(10):1998;2063-2066.
-
(1998)
Cancer Research
, vol.58
, Issue.10
, pp. 2063-2066
-
-
Graff, J.R.1
-
239
-
-
0032752971
-
Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules
-
Gasbarri A.et al. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. Journal of Clinical Oncology. 17(11):1999;3494-3502.
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.11
, pp. 3494-3502
-
-
Gasbarri, A.1
-
240
-
-
0031959770
-
Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death
-
Perillo N.L., Marcus M.E., Baum L.G. Galectins. versatile modulators of cell adhesion, cell proliferation, and cell death Journal of Molecular Medicine. 76(6):1998;402-412.
-
(1998)
Journal of Molecular Medicine
, vol.76
, Issue.6
, pp. 402-412
-
-
Perillo, N.L.1
Marcus, M.E.2
Baum, L.G.3
-
241
-
-
0029157473
-
Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications
-
Xu X.C., el-Naggar A.K., Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. American Journal of Pathology. 147(3):1995;815-822.
-
(1995)
American Journal of Pathology
, vol.147
, Issue.3
, pp. 815-822
-
-
Xu, X.C.1
El-Naggar, A.K.2
Lotan, R.3
-
242
-
-
0242499609
-
Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue
-
Fernandez P.L.et al. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. Journal of Pathology. 181(1):1997;80-86.
-
(1997)
Journal of Pathology
, vol.181
, Issue.1
, pp. 80-86
-
-
Fernandez, P.L.1
-
243
-
-
0035954068
-
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
-
Bartolazzi A.et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 357(9269):2001;1644-1650.
-
(2001)
Lancet
, vol.357
, Issue.9269
, pp. 1644-1650
-
-
Bartolazzi, A.1
-
244
-
-
0030707480
-
Galectin-3: A novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family
-
Akahani S.et al. Galectin-3. a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family Cancer Research. 57(23):1997;5272-5276.
-
(1997)
Cancer Research
, vol.57
, Issue.23
, pp. 5272-5276
-
-
Akahani, S.1
-
245
-
-
0036156211
-
Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia
-
Coli A.et al. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology. 40(1):2002;80-87.
-
(2002)
Histopathology
, vol.40
, Issue.1
, pp. 80-87
-
-
Coli, A.1
-
246
-
-
0033151803
-
Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms
-
Inohara H.et al. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer. 85(11):1999;2475-2484.
-
(1999)
Cancer
, vol.85
, Issue.11
, pp. 2475-2484
-
-
Inohara, H.1
-
247
-
-
0035693445
-
Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas
-
Nascimento M.C.et al. Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas. Endocrine Pathology. 12(3):2001;275-279.
-
(2001)
Endocrine Pathology
, vol.12
, Issue.3
, pp. 275-279
-
-
Nascimento, M.C.1
-
248
-
-
0028672288
-
Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma
-
Figge J.et al. Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Experimental and Molecular Pathology. 61(3):1994;203-211.
-
(1994)
Experimental and Molecular Pathology
, vol.61
, Issue.3
, pp. 203-211
-
-
Figge, J.1
-
249
-
-
0028810936
-
Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid
-
Ermak G.et al. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid. Cancer Research. 55(20):1995;4594-4598.
-
(1995)
Cancer Research
, vol.55
, Issue.20
, pp. 4594-4598
-
-
Ermak, G.1
-
250
-
-
0030044274
-
Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma
-
Ermak G.et al. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Cancer Research. 56(5):1996;1037-1042.
-
(1996)
Cancer Research
, vol.56
, Issue.5
, pp. 1037-1042
-
-
Ermak, G.1
-
251
-
-
0033659718
-
Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma
-
Bohm J.P.et al. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma. Journal of Pathology. 192(3):2000;321-327.
-
(2000)
Journal of Pathology
, vol.192
, Issue.3
, pp. 321-327
-
-
Bohm, J.P.1
-
252
-
-
0032575705
-
A matter of life and cell death
-
Evan G., Littlewood T. A matter of life and cell death. Science. 281(5381):1998;1317-1322.
-
(1998)
Science
, vol.281
, Issue.5381
, pp. 1317-1322
-
-
Evan, G.1
Littlewood, T.2
-
253
-
-
0028564951
-
Specific association of human telomerase activity with immortal cells and cancer
-
Kim N.W.et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 266(5193):1994;2011-2015.
-
(1994)
Science
, vol.266
, Issue.5193
, pp. 2011-2015
-
-
Kim, N.W.1
-
254
-
-
0029395466
-
Aging and cancer - Are telomeres and telomerase the connection?
-
Shay J.W. Aging and cancer - are telomeres and telomerase the connection? Molecular Medicine Today. 1(8):1995;378-384.
-
(1995)
Molecular Medicine Today
, vol.1
, Issue.8
, pp. 378-384
-
-
Shay, J.W.1
-
255
-
-
0029023065
-
Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity
-
Wright W.E., Shay J.W., Piatyszek M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Research. 23(18):1995;3794-3795.
-
(1995)
Nucleic Acids Research
, vol.23
, Issue.18
, pp. 3794-3795
-
-
Wright, W.E.1
Shay, J.W.2
Piatyszek, M.A.3
-
257
-
-
0030061426
-
Telomerase activity - A prevalent marker of malignant human prostate tissue
-
Sommerfeld H.J.et al. Telomerase activity - a prevalent marker of malignant human prostate tissue. Cancer Research. 56(1):1996;218-222.
-
(1996)
Cancer Research
, vol.56
, Issue.1
, pp. 218-222
-
-
Sommerfeld, H.J.1
-
259
-
-
0030979581
-
Multiple pathways to cellular senescence: Role of telomerase repressors
-
Oshimura M., Barrett J.C. Multiple pathways to cellular senescence. role of telomerase repressors European Journal of Cancer. 33(5):1997;705-710.
-
(1997)
European Journal of Cancer
, vol.33
, Issue.5
, pp. 705-710
-
-
Oshimura, M.1
Barrett, J.C.2
-
260
-
-
0032487675
-
Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells
-
Kiyono T.et al. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature. 396(6706):1998;84- 88.
-
(1998)
Nature
, vol.396
, Issue.6706
, pp. 84-88
-
-
Kiyono, T.1
-
261
-
-
0036954835
-
Association of p16(INK4a) and pRb inactivation with immortalization of human cells
-
Tsutsui T.et al. Association of p16(INK4a) and pRb inactivation with immortalization of human cells. Carcinogenesis. 23(12):2002;2111-2117.
-
(2002)
Carcinogenesis
, vol.23
, Issue.12
, pp. 2111-2117
-
-
Tsutsui, T.1
-
262
-
-
0036899106
-
The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis
-
Stavropoulos D.J.et al. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Human Molecular Genetics. 11(25):2002;3135-3144.
-
(2002)
Human Molecular Genetics
, vol.11
, Issue.25
, pp. 3135-3144
-
-
Stavropoulos, D.J.1
-
263
-
-
0030925697
-
Telomerase activity: A marker to distinguish follicular thyroid adenoma from carcinoma
-
Umbricht C.B.et al. Telomerase activity. a marker to distinguish follicular thyroid adenoma from carcinoma Cancer Research. 57(11):1997;2144- 2147.
-
(1997)
Cancer Research
, vol.57
, Issue.11
, pp. 2144-2147
-
-
Umbricht, C.B.1
-
264
-
-
0031440646
-
Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid
-
Saji M.et al. Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid. Surgery. 122(6):1997;1137-1140.
-
(1997)
Surgery
, vol.122
, Issue.6
, pp. 1137-1140
-
-
Saji, M.1
-
265
-
-
0032714457
-
Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms
-
(discussion 1198-9)
-
Zeiger M.A.et al. Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Surgery. 126(6):1999;1195- 1198. (discussion 1198-9).
-
(1999)
Surgery
, vol.126
, Issue.6
, pp. 1195-1198
-
-
Zeiger, M.A.1
-
266
-
-
0023786047
-
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
-
Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335(6189):1988;440-442.
-
(1988)
Nature
, vol.335
, Issue.6189
, pp. 440-442
-
-
Vaux, D.L.1
Cory, S.2
Adams, J.M.3
-
267
-
-
0032575688
-
The Bcl-2 protein family: Arbiters of cell survival
-
Adams J.M., Cory S. The Bcl-2 protein family. arbiters of cell survival Science. 281(5381):1998;1322-1326.
-
(1998)
Science
, vol.281
, Issue.5381
, pp. 1322-1326
-
-
Adams, J.M.1
Cory, S.2
-
268
-
-
0029906324
-
Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland
-
Branet F.et al. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland. Journal of Clinical Endocrinology and Metabolism. 81(7):1996;2726-2730.
-
(1996)
Journal of Clinical Endocrinology and Metabolism
, vol.81
, Issue.7
, pp. 2726-2730
-
-
Branet, F.1
-
269
-
-
0029671093
-
Bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas
-
Pollina L.et al. Bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. British Journal of Cancer. 73(2):1996;139-143.
-
(1996)
British Journal of Cancer
, vol.73
, Issue.2
, pp. 139-143
-
-
Pollina, L.1
-
270
-
-
0028927607
-
The Fas death factor
-
Nagata S., Golstein P. The Fas death factor. Science. 267(5203):1995;1449-1456.
-
(1995)
Science
, vol.267
, Issue.5203
, pp. 1449-1456
-
-
Nagata, S.1
Golstein, P.2
-
272
-
-
0031034933
-
Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
-
Giordano C.et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 275(5302):1997;960-963.
-
(1997)
Science
, vol.275
, Issue.5302
, pp. 960-963
-
-
Giordano, C.1
-
273
-
-
0033346390
-
Fas ligand expression in thyroid carcinomas: A potential mechanism of immune evasion
-
Mitsiades N.et al. Fas ligand expression in thyroid carcinomas. a potential mechanism of immune evasion Journal of Clinical Endocrinology and Metabolism. 84(8):1999;2924-2932.
-
(1999)
Journal of Clinical Endocrinology and Metabolism
, vol.84
, Issue.8
, pp. 2924-2932
-
-
Mitsiades, N.1
-
274
-
-
0032475861
-
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
-
Stambolic V.et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 95(1):1998;29-39.
-
(1998)
Cell
, vol.95
, Issue.1
, pp. 29-39
-
-
Stambolic, V.1
-
275
-
-
0032577699
-
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
-
Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. Journal of Biological Chemistry. 273(22):1998;13375-13378.
-
(1998)
Journal of Biological Chemistry
, vol.273
, Issue.22
, pp. 13375-13378
-
-
Maehama, T.1
Dixon, J.E.2
-
276
-
-
0035920131
-
The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity
-
Gustin J.A.et al. The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. Journal of Biological Chemistry. 276(29):2001;27740-27744.
-
(2001)
Journal of Biological Chemistry
, vol.276
, Issue.29
, pp. 27740-27744
-
-
Gustin, J.A.1
-
277
-
-
0031004088
-
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
-
Liaw D.et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genetics. 16(1):1997;64-67.
-
(1997)
Nature Genetics
, vol.16
, Issue.1
, pp. 64-67
-
-
Liaw, D.1
-
278
-
-
0033843623
-
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors
-
Gimm O.et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. American Journal of the Pathology. 156(5):2000;1693-1700.
-
(2000)
American Journal of the Pathology
, vol.156
, Issue.5
, pp. 1693-1700
-
-
Gimm, O.1
-
279
-
-
0036121266
-
Considerations when analyzing the methylation status of PTEN tumor suppressor gene
-
Zysman M.A., Chapman W.B., Bapat B. Considerations when analyzing the methylation status of PTEN tumor suppressor gene. American Journal of the Pathology. 160(3):2002;795-800.
-
(2002)
American Journal of the Pathology
, vol.160
, Issue.3
, pp. 795-800
-
-
Zysman, M.A.1
Chapman, W.B.2
Bapat, B.3
-
280
-
-
0036094196
-
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation
-
Soria J.C.et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clinical Cancer Research. 8(5):2002;1178-1184.
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.5
, pp. 1178-1184
-
-
Soria, J.C.1
-
281
-
-
0027325132
-
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
-
Oliner J.D.et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 362(6423):1993;857-860.
-
(1993)
Nature
, vol.362
, Issue.6423
, pp. 857-860
-
-
Oliner, J.D.1
-
282
-
-
0033959744
-
MDM2-master regulator of the p53 tumor suppressor protein
-
Momand J., Wu H.H., Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene. 242(1-2):2000;15-29.
-
(2000)
Gene
, vol.242
, Issue.1-2
, pp. 15-29
-
-
Momand, J.1
Wu, H.H.2
Dasgupta, G.3
-
283
-
-
0037099586
-
Tyrosine phosphorylation of Mdm2 by c-Abl: Implications for p53 regulation
-
Goldberg Z.et al. Tyrosine phosphorylation of Mdm2 by c-Abl. implications for p53 regulation EMBO Journal. 21(14):2002;3715-3727.
-
(2002)
EMBO Journal
, vol.21
, Issue.14
, pp. 3715-3727
-
-
Goldberg, Z.1
-
284
-
-
0032963156
-
Analysis of the degradation function of Mdm2
-
Kubbutat M.H.et al. Analysis of the degradation function of Mdm2. Cell Growth and Differentiation. 10(2):1999;87-92.
-
(1999)
Cell Growth and Differentiation
, vol.10
, Issue.2
, pp. 87-92
-
-
Kubbutat, M.H.1
-
286
-
-
0142072360
-
Possible relation of p53 and mdm-2 oncoprotein expression in thyroid carcinoma: A molecular-pathological and immunohistochemical study on paraffin-embedded tissue
-
Schmid K.W.et al. Possible relation of p53 and mdm-2 oncoprotein expression in thyroid carcinoma. a molecular-pathological and immunohistochemical study on paraffin-embedded tissue Endocrine Pathology. 7(2):1996;121-130.
-
(1996)
Endocrine Pathology
, vol.7
, Issue.2
, pp. 121-130
-
-
Schmid, K.W.1
-
287
-
-
0029552270
-
Nuclear accumulation of MDM2 protein in well-differentiated papillary thyroid carcinomas
-
Jennings T.et al. Nuclear accumulation of MDM2 protein in well-differentiated papillary thyroid carcinomas. Experimental Molecular Pathology. 62(3):1995;199-206.
-
(1995)
Experimental Molecular Pathology
, vol.62
, Issue.3
, pp. 199-206
-
-
Jennings, T.1
-
288
-
-
0029009736
-
The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis
-
Zou M.et al. The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis. Cancer. 76(2):1995;314-318.
-
(1995)
Cancer
, vol.76
, Issue.2
, pp. 314-318
-
-
Zou, M.1
-
289
-
-
0035689055
-
P53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland
-
Czyz W.et al. p53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland. Folia Histochemica et Cytobiologica. 39(Suppl. 2):2001;167-168.
-
(2001)
Folia Histochemica et Cytobiologica
, vol.39
, Issue.SUPPL. 2
, pp. 167-168
-
-
Czyz, W.1
-
290
-
-
0035138775
-
Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid: Correlations with clinicopathologic features
-
Horie S.et al. Overexpression of p53 protein and MDM2 in papillary carcinomas of the thyroid. correlations with clinicopathologic features Pathology International. 51(1):2001;11-15.
-
(2001)
Pathology International
, vol.51
, Issue.1
, pp. 11-15
-
-
Horie, S.1
-
291
-
-
0036144177
-
Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays
-
Hoos A.et al. Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays. American Journal of the Pathology. 160(1):2002;175-183.
-
(2002)
American Journal of the Pathology
, vol.160
, Issue.1
, pp. 175-183
-
-
Hoos, A.1
-
292
-
-
0036561908
-
Modelling the molecular circuitry of cancer
-
Hahn W.C., Weinberg R.A. Modelling the molecular circuitry of cancer. Nature Reviews in Cancer. 2(5):2002;331-341.
-
(2002)
Nature Reviews in Cancer
, vol.2
, Issue.5
, pp. 331-341
-
-
Hahn, W.C.1
Weinberg, R.A.2
-
293
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100(1):2000;57-70.
-
(2000)
Cell
, vol.100
, Issue.1
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
|